Brookfield Asset Management (BAM.US) has abandoned its attempt to take Griffon (GRFS.US) private due to valuation differences.
Wednesday, Nov 27, 2024 7:40 am ET
1min read The blood plasma treatment company's shares fell more than 18% before the US market opened Wednesday after several media reports that Brookfield Asset Management (BAM.US) has abandoned its plan to take Grifols (GRFS.US) private.
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.